Cyfuse Biomedical K.K. (TYO:4892)
492.00
-11.00 (-2.19%)
Nov 18, 2026, 10:46 AM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 4.9 billion as of November 17, 2026. It is the 33,263rd most valuable company in the world and the 3,033rd biggest in Japan. Its market cap has increased by 1.60% in one year.
Market Cap
4.90B
Enterprise Value
2.91B
Revenue
283.00M
Global Rank
Country Rank
#3,033 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 4.90B, a decrease of -62.30%. That is a compound annual growth rate of -21.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 4.90B | -13.56% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
| Dec 1, 2022 | 13.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 6.13B |
| OncoTherapy Science | 6.12B |
| J-Pharma | 6.05B |
| Chiome Bioscience | 5.92B |
| Soiken Holdings | 5.49B |
| BrightPath Biotherapeutics | 5.42B |
| CellSource | 5.40B |
| MabGenesis | 5.36B |